Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors von Cives, M, Kunz, P L, Morse, B, Coppola, D, Schell, M J, Campos, T, Nguyen, P T, Nandoskar, P, Khandelwal, V, Strosberg, J R

Volltext

Production and reproduction of Fleckvieh, Brown Swiss, and 2 strains of Holstein-Friesian cows in a pasture-based, seasonal-calving dairy system von Piccand, V., Cutullic, E., Meier, S., Schori, F., Kunz, P.L., Roche, J.R., Thomet, P.

Volltext

Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors von Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., Bushnell, D., O'Dorisio, T. M., Baum, R. P., Kulkarni, H. R., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., Van Cutsem, E., Benson, A., Srirajaskanthan, R., Pavel, M., Mora, J., Berlin, J., Grande, E., Reed, N., Seregni, E., Öberg, Kjell, Sierra, M. Lopera, Santoro, P., Thevenet, T., Erion, J. L., Ruszniewski, P., Kwekkeboom, D., Krenning, E.

Volltext

Interactions Between Body Condition at Calving and Cooling of Dairy Cows During Lactation in Summer von Flamenbaum, I, Wolfenson, D, Kunz, P. L, Maman, M, Berman, A

Volltext

Reduced and Compensatory Growth: Endocrine and Metabolic Changes during Food Restriction and Refeeding in Steers von Blum, J.W., Schnyder, W., Kunz, P.L., Blom, A.K., Bickel, H., Schürch, A.

Volltext

Longer term efficacy of lanreotide autogel/depot (LAN) for symptomatic treatment of carcinoid syndrome (CS) in neuroendocrine tumor (NET) patients from the ELECT open label study von Fisher, G.A., Wolin, E., Kunz, P.L., Liyanage, N., Mirakhur, B., Lowenthal, S. Pitman, Pommier, R.F., Shaheen, M., Vinik, A.

Volltext

NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: Efficacy, safety, QoL results and subgroup analysis von Strosberg, J., Wolin, E., Chasen, B., Kulke, M., Bushnell, D., Caplin, M., Baum, R., Kunz, P.L., Hobday, T., Hendifar, A., Oberg, K., Sierra, M. Lopera, Kwekkeboom, D., Ruszniewski, P., Krenning, E.

Volltext

Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome von Kulke, M., Hörsch, D., Caplin, M., Anthony, L., Bergsland, E., Oberg, K., Welin, S., Warner, R., Bohas, C. Lombard, Kunz, P.L., Grande, E., Valle, J.W., Lapuerta, P., Banks, P., Jackson, S., Jiang, W., Biran, T., Pavel, M.

Volltext

Efficacy of lanreotide autogel/depot (LAN) vs placebo (PBO) for symptomatic control of carcinoid syndrome (CS) in neuroendocrine tumor (NET) patients from the ELECT study von Wolin, E.M., Fisher, G.A., Kunz, P.L., Liyanage, N., Lowenthal, S.P., Mirakhur, B., Pommier, R.F., Shaheen, M., Vinik, A.

Volltext

Phase I, open-label, dose-escalation study of SNX-5422 plus everolimus in neuroendocrine tumors (NETs) von Gutierrez, M.E., Giaccone, G., Liu, S.V., Rajan, A., Guha, U., Halfdanarson, T.R., Curtis, K.K., Kunz, P.L., Gabrail, N., Hinson, J.M., Orlemans, E.O.

Volltext

NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: Efficacy, safety, QoL results and subgroup analysis von Strosberg, J., Wolin, E., Chasen, B., Kulke, M., Bushnell, D., Caplin, M., Baum, R., Kunz, P. L., Hobday, T., Hendifar, A., Öberg, Kjell E., Sierra, M. Lopera, Kwekkeboom, D., Ruszniewski, P., Krenning, E.

Volltext

Molecular Analysis and Prenatal Diagnosis of Human Fumarase Deficiency von Coughlin, Eleanor M., Christensen, Ernst, Kunz, Pamela L., Krishnamoorthy, K.S., Walker, Valerie, Dennis, N.R., Chalmers, Ronald A., Elpeleg, Orly N., Whelan, Donald, Pollitt, R.J., Ramesh, Vijaya, Mandell, Roseann, Shih, Vivian E.

Volltext

Long-term survivorship in gastric cancer von Kunz, P. L., Gubens, M. A., Fisher, G. A., Ford, J. M., Lichtensztajn, D., Clarke, C. A.

Volltext

Long-term survivorship in pancreatic adenocarcinoma von Gubens, M. A., Kunz, P. L., Fisher, G. A., Ford, J. M., Lichtensztajn, D., Clarke, C. A.

Volltext

Carboplatin and fluoropyrimidine-based treatment for metastatic gastric and gastroesophageal junction cancer: A retrospective review of the Stanford experience von Kunz, P. L., de Bruin, M. A., Balise, R. R., Fisher, G. A., Ford, J. M.

Volltext

A phase I study of an oral formulation of ixabepilone (ixa) in patients with advanced cancer von He, A. R., Kunz, P. L., Pishvaian, M. J., Colevas, A. D., Hwang, J. J., Clemens, P. L., Messina, M., Kaleta, R., Abrahao, F., Sikic, B. I.

Volltext

Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U.S. experience von Smyth, E. C., Enzinger, P. C., Li, J., Vincitore, M., Lacy, J., El-Rayes, B. F., Kunz, P. L., Ford, J. M., Robinson, E., Kelsen, D. P., Shah, M. A.

Volltext

Treatment of pancreatic cancer in patients age 70 or older von Christman-Skieller, C., Heestand, G. M., Fisher, G. A., Kunz, P. L., Ford, J. M., Columbo, L. A., Chang, D. T., Koong, A.

Volltext

A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors von Kunz, P. L., Kuo, T., Zahn, J. M., Kaiser, H. L., Norton, J. A., Visser, B. C., Longacre, T. A., Ford, J. M., Balise, R. R., Fisher, G. A.

Volltext

A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors: Preliminary results von Kunz, P. L., Kuo, T., Kaiser, H. L., Norton, J. A., Longacre, T. A., Ford, J. M., Fisher, G. A.

Volltext